arrow
B

Brian C. Miller

broad institute of mit and harvard
H指数:22
被引数:8,169

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer

CRISPR筛选识别恢复癌症中年龄相关T细胞功能障碍的靶点

Cell
IF42.5
2026-07-290
PRE
Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer

基于结构的C型化学趋化因子受体2(CCR2)靶向双旁特异抗体在 triple negative breast cancer 中的设计与工程化

2025-10-150
OAAI
Intra-tumoral hypoxia promotes CD8+ T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4

肿瘤内缺氧通过慢性激活整合应激反应转录因子ATF4促进CD8+ T细胞功能障碍

Immunity
IF26.3
2025-09-250
OAAI
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)

给予雄激素受体途径抑制剂的转移性去势抵抗性前列腺癌患者的克隆造血和临床结局 (联盟A031201)

2024-09-180
PRE
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control
2024-09-170
PRE
Deciphering the effects of age on T cell immunity and immunotherapy
2024-03-220
PRE
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes

神经母细胞瘤中的间充质和肾上腺素能细胞谱系状态具有不同的免疫原性表型

2022-09-2233
OA
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity

SETDB1的表观遗传沉默抑制肿瘤内在免疫原性

Nature
IF48.5
2021-05-050
PREAI
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade (vol 20, pg 326, 2019)
2019-10-0313
OAAI
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

耗竭的CD8 T细胞亚群差异介导肿瘤控制并响应检查点阻断

2019-02-181.3K
OAAI